Altimmune

February 19, 2021 | Maryam Shahzad

Altimmune Announces FDA Approval for Phase 1 COVID-19 Vaccine Clinical Trials 

Altimmune, Inc. announced Wednesday that it was approved by the FDA to begin Phase 1 clinical trials for AdCOVID, its single-dose nasal spray COVID-19 vaccine candidate. The clinical stage biopharmaceutical company, headquartered in Gaithersburg, expects to begin volunteer enrollment in the trials in the coming week, according to a statement from the company. “We believe […]

Read more

February 19, 2021 | Jasmine Boykin

Company Working on Potential COVID-19 Nasal Vaccine Looks to Expand in Montgomery County

Vigene Biosciences, a Maryland-based biotechnological company whose projects include a potential COVID-19 nasal spray vaccine, is looking to expand in Montgomery County with a new facility in Rockville. The new facility, which will be located at 14200 Shady Grove Road, will encompass 52,000 square feet of manufacturing space for its 125 current employees and hopes […]

Read more

Engage us on Facebook

Follow us on Twitter